Fu L, Zhou X, Zhang X, Li X, Zhang F, Gu H
J Hematol Oncol. 2025; 18(1):29.
PMID: 40069858
PMC: 11900646.
DOI: 10.1186/s13045-025-01673-7.
Bursacovschi D, Revenco V, Robu M, Arnaut O
Diagnostics (Basel). 2025; 15(4).
PMID: 40002568
PMC: 11854496.
DOI: 10.3390/diagnostics15040417.
Tang S, Cao J, Jiang D, Zhu L, Luo Z, Shan S
Ann Hematol. 2025; .
PMID: 39992428
DOI: 10.1007/s00277-025-06261-w.
Al-Amodi H, Bedair H, Gohar S, Mohamed D, Abd El Gayed E, Nazih M
Int J Mol Sci. 2025; 26(3).
PMID: 39941037
PMC: 11818594.
DOI: 10.3390/ijms26031269.
Azevedo P, Zuppo Laper I, Oliveira D, Sabino A, Garcia M, de Freitas I
Front Pharmacol. 2025; 15:1414244.
PMID: 39867655
PMC: 11758161.
DOI: 10.3389/fphar.2024.1414244.
Decoding the mechanisms behind second primary cancers.
Zeng M, Lin A, Jiang A, Qiu Z, Zhang H, Chen S
J Transl Med. 2025; 23(1):115.
PMID: 39856672
PMC: 11762917.
DOI: 10.1186/s12967-025-06151-9.
Upregulation of CD19 by low-dose chidamide promotes CAR T cells functionality in B-cell non-Hodgkin lymphoma.
Ni Y, Zhang Q, Tang X, Li X, Ye S, Lu Y
Discov Oncol. 2025; 16(1):84.
PMID: 39853608
PMC: 11759751.
DOI: 10.1007/s12672-025-01810-1.
Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphoma.
Jing Q, Wu Y, Li Y, Zhou C, Zhang J, Xia J
Biol Direct. 2025; 20(1):7.
PMID: 39815362
PMC: 11734572.
DOI: 10.1186/s13062-025-00594-2.
Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth.
Xing Y, Tan C, Liu Z, Liu Y, Liu S, Wang G
J Nat Med. 2025; 79(2):399-411.
PMID: 39815148
PMC: 11880072.
DOI: 10.1007/s11418-024-01873-4.
Development of Hemispherical 3D Models of Human Brain and B Cell Lymphomas Using On-Chip Cell Dome System.
Kazama R, Ishikawa R, Sakai S
Bioengineering (Basel). 2025; 11(12.
PMID: 39768123
PMC: 11727638.
DOI: 10.3390/bioengineering11121303.
Whole-Cell Vaccine Preparation Through Prussian Blue Nanoparticles-Elicited Immunogenic Cell Death and Loading in Gel Microneedles Patches.
Fu W, Li Q, Sheng J, Wu H, Ma M, Zhang Y
Gels. 2024; 10(12).
PMID: 39727596
PMC: 11675167.
DOI: 10.3390/gels10120838.
NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.
Cecchetti S, Federici C, Canese R, Iorio E, Huber V, Pisanu M
Front Immunol. 2024; 15:1503857.
PMID: 39712029
PMC: 11659271.
DOI: 10.3389/fimmu.2024.1503857.
Institutional Experience of Lymphoproliferative Disorders with Initial Diagnosis Made via Fine Needle Aspiration at Otolaryngology Clinic.
Hrizat A, Gong J, Gargano S
Acta Med Acad. 2024; 53(3):274-285.
PMID: 39655354
PMC: 11831544.
DOI: 10.5644/ama2006-124.456.
Artificial Intelligence Applications in Lymphoma Diagnosis and Management: Opportunities, Challenges, and Future Directions.
Shen M, Jiang Z
J Multidiscip Healthc. 2024; 17:5329-5339.
PMID: 39582879
PMC: 11583773.
DOI: 10.2147/JMDH.S485724.
Causal association of physical activity with lymphoma risk: a Mendelian randomization analysis.
Zhao J, Wen X, Zheng M, Su L, Guo X
Eur J Public Health. 2024; 35(1):121-127.
PMID: 39570117
PMC: 11832145.
DOI: 10.1093/eurpub/ckae172.
Autoimmune Diseases and Risk of Non-Hodgkin Lymphoma: A Mendelian Randomisation Study.
Shi X, Wallach J, Ma X, Rogne T
Cancer Med. 2024; 13(21):e70327.
PMID: 39506244
PMC: 11540836.
DOI: 10.1002/cam4.70327.
Antibody blockade of the PSGL-1 immune checkpoint enhances T-cell responses to B-cell lymphoma.
Pereira J, Arede L, Ferreira F, Matos A, Pereira D, Santos R
Leukemia. 2024; 39(1):178-188.
PMID: 39455852
DOI: 10.1038/s41375-024-02446-w.
Development and validation of a hierarchical approach for lymphoma classification using immunohistochemical markers.
Xu J, Shi Y, Cui M, Wang Y, Fan W, Yun J
Cancer Med. 2024; 13(20):e70120.
PMID: 39444262
PMC: 11499568.
DOI: 10.1002/cam4.70120.
Metabolite, immunocyte phenotype, and lymphoma: a Mendelian randomization study.
Fan C, Yuan P, Yang X, Zhang W, Wang X, Xie J
Front Immunol. 2024; 15:1431261.
PMID: 39386202
PMC: 11461196.
DOI: 10.3389/fimmu.2024.1431261.
Unraveling the complex role of neutrophils in lymphoma: From pathogenesis to therapeutic approaches (Review).
Wang K, Wang X, Song L
Mol Clin Oncol. 2024; 21(5):85.
PMID: 39347476
PMC: 11428085.
DOI: 10.3892/mco.2024.2783.